AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says

By Business Insider   |   15 hours ago
AI can call the shots on drug making because it 'doesn't have a career at stake,' major pharma CEO says

Paul Hudson, CEO of Sanofi, discussed the benefits of using AI for decision-making in medicine at Davos. AI's impartiality and lack of attachment to projects or careers can provide valuable insights, aiding in drug development processes.

Read More

Did you find this insightful?